Consultation with a specialist is required as contraindications may apply.
ESA Global Lens
We invite you to familiarise yourself with our product called
ESA OK-therapy. It is already widely used to help patients with myopia, especially children and adolescents with progressive myopia
Skip animation
ESA OK-therapy. It is already widely used to help patients with myopia, especially children and adolescents with progressive myopia
ESA OK-therapy is personalised clinical orthokeratology, which consists of three main elements:
SimuLENS® virtual fitting platform
It is itself a huge inventory set of nearly 10,000 back surfaces, and has a built-in calculator that allows you to calculate the ESA® lens effect (target power).
Learn more
Myopia has become a pandemic in recent decades, and the trend continues
It mainly progresses between the ages of 10 and 17 and it is important to intervene during this period and slow down this progression.
Orthokeratology is the most effective optical method, which is second only to atropine in high and medium doses.
Holden BA et al. Ophthalmology 2016;123(5):1036-42
Number of people (in millions) per year
ESA OK-therapy is already widely used to help patients with myopia, especially children and adolescents with progressive myopia, and has proven to be effective
Leave a request to contact us
Plumpton House, Plumpton Road, Hoddesdon, Hertfordshire EN11 0LB, UK
Telephone:
+44 1992 448359
Email:
info@esalens.com
Esa Global Lens